U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H13N3O5S
Molecular Weight 287.292
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NIFURTIMOX

SMILES

CC1CS(=O)(=O)CCN1\N=C\C2=CC=C(O2)[N+]([O-])=O

InChI

InChIKey=ARFHIAQFJWUCFH-IZZDOVSWSA-N
InChI=1S/C10H13N3O5S/c1-8-7-19(16,17)5-4-12(8)11-6-9-2-3-10(18-9)13(14)15/h2-3,6,8H,4-5,7H2,1H3/b11-6+

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
NIFURTIMOX
INN   MART.   MI   USAN   WHO-DD   WHO-IP  
INN   USAN  
Official Name English
BAYER-2502
Code English
4-[(5-Nitrofurfurylidene)amino]-3-methylthiomorpholine 1,1-dioxide
Systematic Name English
NIFURTIMOX [USAN]
Common Name English
NIFURTIMOX [ORANGE BOOK]
Common Name English
NIFURTIMOX [MART.]
Common Name English
NIFURTIMOX [WHO-IP]
Common Name English
Nifurtimox [WHO-DD]
Common Name English
BAYER 2502
Code English
THIOMORPHOLINE, 3-METHYL-4-((5-NITROFURFURYLIDENE)AMINO)-, 1,1-DIOXIDE
Systematic Name English
4-THIOMORPHOLINAMINE, 3-METHYL-N-((5-NITRO-2-FURANYL)METHYLENE)-, 1,1-DIOXIDE
Systematic Name English
DNDI1613515
Code English
(RS)-3-METHYL-N-((1E)-(5-NITRO-2-FURYL)METHYLENE)THIOMORPHOLIN-4-AMINE 1,1-DIOXIDE
Systematic Name English
BAY-2502
Code English
NIFURTIMOX [MI]
Common Name English
nifurtimox [INN]
Common Name English
BAY-A2502
Code English
TETRAHYDRO-3-METHYL-4-((5-NITROFURFURYLIDENE)AMINO)-4H-1,4-THIAZINE 1,1-DIOXIDE
Systematic Name English
LAMPIT
Brand Name English
(±)-NIFURTIMOX
Common Name English
NIFURTIMOXUM [WHO-IP LATIN]
Common Name English
Classification Tree Code System Code
WHO-ESSENTIAL MEDICINES LIST 6.5.5.1
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
WHO-VATC QP51AC01
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
FDA ORPHAN DRUG 310110
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 6.5.5.2
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
NCI_THESAURUS C277
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
FDA ORPHAN DRUG 419213
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
WHO-ATC P01CC01
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
Code System Code Type Description
MERCK INDEX
m7892
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB11820
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
LACTMED
Nifurtimox
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
ECHA (EC/EINECS)
245-531-0
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
SMS_ID
100000083878
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
ChEMBL
CHEMBL290960
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
RXCUI
7421
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY RxNorm
DAILYMED
M84I3K7C2O
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
EPA CompTox
DTXSID3045439
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
MESH
D009547
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
CAS
23256-30-6
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
WIKIPEDIA
Nifurtimox
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
EVMPD
SUB09280MIG
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
USAN
CD-134
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
INN
2615
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
DRUG CENTRAL
1929
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
FDA UNII
M84I3K7C2O
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
NIFURTIMOX
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY Description: A yellow to orange-yellow, crystalline powder; odourless. Solubility: Practically insoluble in water and ether R; freely soluble in dimethylformamide R; sparingly soluble in dioxan R. Category: Antitrypanosomal drug. Storage: Nifurtimox should be kept in a well-closed container. Definition: Nifurtimox contains not less than 98.0% and not more than 102.0% of C10H13N3O5S, calculated with reference to thedried substance.
PUBCHEM
6842999
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
NCI_THESAURUS
C71734
Created by admin on Sat Dec 16 05:43:39 UTC 2023 , Edited by admin on Sat Dec 16 05:43:39 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of NIFURTIMOX
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966